Predicting metabolic syndrome by using hematogram models in elderly women

References

• Mozumdar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999–2006. Diabetes Care 2011;34:216–219
   PubMed Web of Science ®Google Scholar
• Hanley AJ, Retnakaran R, Qi Y, Gerstein HC, Perkins B, Raboud J, Harris SB, Zinman B. Association of hematological parameters with insulin resistance and beta-cell dysfunction in nondiabetic subjects. J Clin Endocrinol Metab 2009;94:3824–3832
   PubMed Web of Science ®Google Scholar
• Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G; Atherosclerosis Risk in Communities Study. Low-grade systemic inflammation and the development of type 2 diabetes: The atherosclerosis risk in communities study. Diabetes 2003;52:1799–1805
   PubMed Web of Science ®Google Scholar
• Fadini GP, Marcuzzo G, Marescotti MC, de Kreutzenberg SV, Avogaro A. Elevated white blood cell count is associated with prevalence and development of the metabolic syndrome and its components in the general population. Acta Diabetol. 2012;49(6):445--51. doi: 10.1007/s00592-012-0402-5
   Google Scholar
• Odagiri K, Uehara A, Mizuta I, Yamamoto M, Kurata C. Longitudinal study on white blood cell count and the incidence of metabolic syndrome. Intern Med 2011;50:2491–2498
   PubMedGoogle Scholar
• Nakanishi N, Suzuki K, Tatara K. White blood cell count and clustered features of metabolic syndrome in Japanese male office workers. Occup Med (Lond) 2002;52:213–218
   PubMed Web of Science ®Google Scholar
• Lee YJ, Shin YH, Kim JK, Shim JY, Kang DR, Lee HR. Metabolic syndrome and its association with white blood cell count in children and adolescents in Korea: The 2005 Korean National Health and Nutrition Examination Survey. Nutr Metab Cardiovasc Dis 2010;20:165–172
   PubMed Web of Science ®Google Scholar
• Chen YL, Hsu CH, Hseih CH, Wang K, Wu CZ, Wang CY, Wang JY, Chang JB, Pei D. Association between platelet count and components of metabolic syndrome in geriatric Taiwanese women. Int J Gerontol 2012;6(3):201--205
   Google Scholar
• Kutlucana A, Bulurb S, Kıra S, Bulur S, Önder E, Aslantaş Y, Ekinözü İ, Aydn Y, Özhan H. The relationship between mean platelet volume with metabolic syndrome in obese individuals. Blood Coagulation Fibrinol 2012;23:388–390
   PubMedGoogle Scholar
• Shimakawa T, Bild DE. Relationship between hemoglobin and cardiovascular risk factors in young adults. J Clin Epidemiol 1993;46:1257–1266
   PubMed Web of Science ®Google Scholar
• Barbieri M, Ragno E, Benvenuti E, Zito GA, Corsi A, Ferrucci L, Paolisso G. New aspects of the insulin resistance syndrome: impact on haematological parameters. Diabetologia 2001;44:1232–1237
   PubMed Web of Science ®Google Scholar
• Hanley AJG, Retnakaran R, Qi Y, Gerstein HC, Perkins B, Raboud J, Harris SB, Zinman B. Association of hematological parameters with insulin resistance and β-cell dysfunction in nondiabetic subjects. Endocrine Care 2009;94:3824–3832
   Google Scholar
• Hwang LC, Bai CH, Chen CJ. Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc 2006;105:626–635
   PubMed Web of Science ®Google Scholar
• Lin CC, Liu CS, Lai MM, Li CI, Chen CC, Chang PC, Lin WY, Lee YD, Lin T, Li TC. Metabolic syndrome in a Taiwanese metropolitan adult population. BMC Public Health 2007;7:239 . doi:10.1186/1471-2458-7-239
   PubMedGoogle Scholar
• Stone NJ, Bilek S, Rosenbaum S. Recent national cholesterol education program adult treatment panel III update: Adjustments and options. Am J Cardiol 2005;96:53E–59E
   PubMed Web of Science ®Google Scholar
• Bureau of Health Promotion, Department of Health, R.O.C. (Taiwan). Available at: http://www.bhp.doh.gov.tw/BHPNet/Web/HealthTopic/TopicArticle.aspx?id=200712250123&Class=2&parentid=200712250023 (last accessed 10 Feb 2013)
   Google Scholar
• Wang LM, Myers Jr MG, Sun KJ, Aaronson SA, White M, Pierce JH. IRS-1: Essential for insulin and Il-4 stimulated mitogenesis in hematopoietic cells. Sience1993;261:1591–1594
   Google Scholar
• Tateishi N, Suzuki Y, Shirai M, Cicha I, Maeda N. Reduced oxygen release from erythrocytes by the acceleration-induced flow shift, observed in an oxygen-permeable narrow tube. J Biomech 2002;35:1241–1251
   PubMedGoogle Scholar
• Baskurt OK, Yalcin O, Ozdem S, Armstrong JK, Meiselman HJ. Modulation of endothelial nitric oxide synthase expression by red blood cell aggregation. Am J Physiol Heart Circ Physiol 2004;286:H222–H229
   PubMed Web of Science ®Google Scholar
• Jesri A, Okonofua EC, Egan BM. Platelet and white blood cell counts are elevated in patients with the metabolic syndrome. J Clin Hypertens (Greenwich) 2005;7:705–711
   PubMedGoogle Scholar
• Kotani K, Sakane N, Saiga K, Mu H, Kurozawa Y. Clustered components of the metabolic syndrome and platelet counts in Japanese females. Clin Chem Lab Med 2007;45:376–379
   PubMed Web of Science ®Google Scholar
• Turakhia MP, Murphy SA, Pinto TL, Antman EM, Giugliano RP, Cannon CP, Braunwald E, Gibson CM; Thrombolysis in Myocardial Infarction Study Group. Association of platelet count with residual thrombus in the myocardial infarctrelated coronary artery among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction. Am J Cardiol 2004;94:1406–1410
   PubMed Web of Science ®Google Scholar
• Taniguchi A, Fukushima M, Seino Y, Sakai M, Yoshii S, Nagasaka S, Yamauchi I, Okumura T, Nin K, Tokuyama K, et al. Platelet count is independently associated with insulin resistance in non-obese Japanese type 2 diabetic patients. Metabolism 2003;52:1246–1249
   PubMed Web of Science ®Google Scholar
• De Pergola G, Pannacciulli N, Coviello M, Scarangella A, Di Roma P, Caringella M, Venneri MT, Quaranta M, Giorgino R. sP-selectin plasma levels in obesity: Association with insulin resistance and related metabolic and prothrombotic factors. Nutr Metab Cardiovasc Dis 2008;18:227–232
   PubMed Web of Science ®Google Scholar
• Trovati M, Mularoni EM, Burzacca S, Ponziani MC, Massucco P, Mattiello L, Piretto V, Cavalot F, Anfossi G. Impaired insulin-induced platelet antiaggregating effect in obesity and in obese NIDDM patients. Diabetes 1995;44:1318–1322
   PubMed Web of Science ®Google Scholar
• Santilli F, Vazzana N, Liani R, Guagnano MT, Davì G. Platelet activation in obesity and metabolic syndrome. Obesity Rev 2012;13:27–42
   PubMed Web of Science ®Google Scholar
• Wagner DD, Burger PC. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 2003;23:2131–2137
   PubMed Web of Science ®Google Scholar
• Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007;357:2482–2494
   PubMed Web of Science ®Google Scholar